NYXH Nyxoah SA NASDAQ · United States

Nyxoah SA (NYXH) news

Nyxoah SA is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NYXH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Nyxoah SA news

We have not published a story on Nyxoah SA yet. When there is news, it will appear here.

Nyxoah SA annual financials

Line	FY2025	FY2024
Research and development	€42.8 million	€34.3 million
Net income (loss)	-€90.1 million	-€59.2 million
Cash from operations	-€69.0 million	-€49.2 million
Cash and equivalents	€30.0 million	€34.2 million

Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents €30.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Nyxoah SA

What is the ticker symbol of Nyxoah SA?

Nyxoah SA trades under the ticker NYXH on NASDAQ.

Where is Nyxoah SA listed?

Nyxoah SA is listed on NASDAQ.

Which country or territory is Nyxoah SA listed under?

Our directory records Nyxoah SA under United States.

Does aibio.space cover Nyxoah SA?

aibio.space lists Nyxoah SA among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: Nyxoah SA

Members talk about Nyxoah SA (NYXH). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Nyxoah SA, newest first. Each line links the filing it comes from.

Jun 23, 2026Financings
Reported a financing. SEC Form 6-K. Source
Jun 4, 2026Financings
Reported a financing. SEC Form 424B5. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:NYXH on TradingView.

Listing details

Company: Nyxoah SA
Ticker: NYXH
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction